I enjoy working with clients for the full life cycle of the company, from formation to exit and everything in between.
Anna Snook focuses her practice on advising private companies on a wide range of corporate matters, including formation, financings, mergers and acquisitions, and general corporate governance matters. Anna also advises public companies on public and private offerings of equity, SEC reporting obligations, and general corporate governance matters.
In addition to her daily practice, Anna co-leads the firm’s Women Associates Group, which serves as a safe space for discussion of issues affecting women in and outside of the firm, promotes advancement of women and networking in the firm, and facilitates discussions of current events affecting women professionals.
Cala Systems, producer of the world's first intelligent heat pump water heater, in its $5.6 million seed funding
Kula Bio, a leader in sustainable nitrogen solutions, in a $50 million Series A financing and a $10 million Series Seed financing
Pear Therapeutics, Inc., a pioneer of prescription digital therapeutics, in connection with its $80 million Series D Financing led by SoftBank Vision Fund 2
7AC Technologies, a developer of ultra-high efficiency HVAC systems, in its sale to Emerson Electric
Glympse Bio, a biotechnology company advancing the way diseases are understood, tracked and treated, in its $46.7 million Series B financing
Energetic Insurance, a Managing General Underwriter (MGU), in its initial $2.5 million Series Seed financing
Honest Buildings, a real estate project management platform in its sale to Procore Technologies, a leading provider of construction management software
Pika Energy, a manufacturer of innovative battery storage technologies, in its sale to power products manufacturer Generac Holdings
Tank Utility, a provider of IoT tank monitoring and logistics optimization services, in a financing round led by Bullpen Capital
CredSimple, an NCQA certified credentialing and provider data management solution, in its acquisition of Glenridge Health, a technology-enabled provider network management solutions company
PUBLIC COMPANY REPRESENTATIVE EXPERIENCE
AstroNova, Inc. (Nasdaq: ALOT), a leading provider of mission critical identification and marking solutions across the aerospace & defense and labeling & packaging industries, in its acquisition by Arcline Investment Management, a growth-oriented private equity firm for $272 million
Enanta Pharmaceuticals, Inc. (Nasdaq: ENTA), a clinical-stage biotechnology company, on its $74.8 million public offering, which included the underwriters’ full exercise of their option to purchase additional shares
Pear Therapeutics, Inc. (Nasdaq: PEAR), a pioneer of prescription digital therapeutics, in a SPAC IPO/reverse merger of Pear Therapeutics, Inc. with and into a wholly owned subsidiary of Thimble Point Aquisition Corp. (THMA), with Pear Therapeutics, Inc. surviving the merger and THMA changing its name to Pear Therapeutics, Inc.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a multi-state cannabis operator, in closing an underwritten public offering of approximately US$228 million of subordinate voting shares
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company, in:
its $130 million PIPE of Series A Convertible Preferred Stock
its $64.7 million underwritten public offering of Class A common stock
its $50.3 million underwritten public offering of Class A common stock
Honors & Involvement
HONORS
Best Lawyers: Ones to Watch - Venture Capital Law (2023-2027), Leveraged Buyouts and Private Equity Law (2026-2027), Mergers and Acquisitions Law (2026-2027), and Securities / Capital Markets Law (2026-2027)
Speaking Engagements
Speaker, “SHOW HER THE MONEY,” Babson College (October 2025)
Speaker, “Beyond Silicon Valley: Startup & Investing Insights from Australia & New Zealand,” Foley Hoag + Dispute Buddy (October 2025)
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
